Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals

SEATTLE, Nov. 28 On Monday, December 1, 2008, at8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members ofCell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team willhost a conference call to discuss the agreement with Spectrum Pharmaceuticalsof Irvine, California to jointly market and develop Zevalin(R).

Live audio webcast at www.celltherapeutics.com will be archived for postlistening approximately two hours after call endsConference Call Numbers Monday, December 1 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time 1-800-219-6110 (US Participants) 1-303-262-2053 (International) Call-back numbers for post-listening available at 11:30 a.m. Eastern: 1-800-405-2236 (US Participants) 1-303-590-3000 (International) Passcode: 11123066#

SOURCE Cell Therapeutics, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...